Therapy management and outcome of acute hydrocephalus secondary to intraventricular hemorrhage in adults
Chaoyang Wang(Zhejiang Cancer Hospital), Yong Cao(University of Chinese Academy of Sciences), Yuming Jiao(Capital Medical University), Xianwei Zeng(Shandong University), Shaozhi Zhao(Beijing Tian Tan Hospital), Qifeng Yu(Capital Medical University), Jie Wang(Fudan University), Wenqian Zhang(BGI Group (China)), Yingfan Sun, Zhiyou Wu(Dana-Farber Cancer Institute), Hongyuan Xu(Beijing Tian Tan Hospital), Jinyi Tang(Carter Center), Jianuo Bai(Capital Medical University), Qiheng He(Capital Medical University), Ran Huo(Soochow University), Wuyang Yang(Research Institute of Petroleum Exploration and Development)
Cited by 5
Related Papers
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
|Genome Biology|2015|429
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination
|Science Immunology|2022|366
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients
|Signal Transduction and Targeted Therapy|2021|210
Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models
|Science Translational Medicine|2022|129